AnaptysBio, Inc. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported net loss was USD 44.26 million compared to USD 36.26 million a year ago. Basic loss per share from continuing operations was USD 1.58 compared to USD 1.31 a year ago.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
23.74 USD | +0.53% | -0.55% | +10.18% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.18% | 645M | |
+18.55% | 125B | |
+14.85% | 108B | |
-6.43% | 23.64B | |
+2.39% | 22.39B | |
-12.11% | 17.78B | |
-41.64% | 16.43B | |
-12.95% | 16.34B | |
+0.83% | 13.56B | |
+25.60% | 11.59B |
- Stock Market
- Equities
- ANAB Stock
- News AnaptysBio, Inc.
- AnaptysBio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023